Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

8 NSCLC cell lines treated with either 50nM or 100nM of AUY for 24 hours.

ABSTRACT: RNA from treated cell lines are compared to RNA from matched untreated samples on the same chip to assess differential gene expression.

ORGANISM(S): Homo sapiens

PROVIDER: GSE43568 | GEO | 2013/01/18

SECONDARY ACCESSION(S): PRJNA186733

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

8 NSCLC cell lines treated with either 50nM or 100nM of AUY for 24 hours.

Project description:RNA from treated cell lines are compared to RNA from matched untreated samples on the same chip to assess differential gene expression. RNA from treated cell lines are compared to RNA from matched untreated samples on the same chip to assess differential gene expression.

2013-01-18 | E-GEOD-43568 | biostudies-arrayexpress

8 NSCLC cell lines treated with either 50nM or 100nM of AUY for 24 hours

| S-ECPF-GEOD-43568 | biostudies-other

RNAseq of U251 cell line treated with 100nM of LLY-283 for 24 hours

Project description:RNAseq analysis of U251 cell line treated with 100nM of LLY-283 compared to Vehicle treated cells to analyse the effect of LLY-283 on gene expression and mRNA splicing.

2024-08-02 | GSE264609 | GEO

Harvesting secreted proteins from cell lines after 24 hours hypoxia

Project description:Cancers are often associated with hypoxia and metabolic reprogramming, resulting in enhanced tumor progression. Here, we aimed to study breast cancer hypoxia responses, focusing on secreted proteins from low-grade (luminal-like) and high-grade (basal-like) cell lines before and after hypoxia.

2023-06-23 | PXD040532 | Pride

NSCLC cells treated with Gefitinib

2011-01-27 | GSE23206 | GEO

RNAseq of U251 cell line treated with 100nM of LLY-283 for 24 hours

Project description:RNAseq of U251 cell line treated with 100nM of LLY-283 for 24 hours

| PRJNA1103235 | ENA

Tet-ZFP36L1 in 6 hours and 24 hours

Project description:ZFP36L1 is a tandem zinc-finger RNA-binding protein that recognizes conserved Adenylate-Uridylate-rich Elements (AREs) located in 3' untranslated regions (UTRs) to mediate RNA decay. We hypothesized that ZFP36L1 is a negative regulator of a post-transcriptional hub involved in the RNA half-life regulation of cancer-related transcripts. Forced expression of ZFP36L1 in cancer cells markedly reduced cell proliferation in vitro and in vivo; whereas silencing of ZFP36L1 enhanced tumor cell growth. To identify direct downstream targets of ZFP36L1, systematic screening using RNA pull-down of wildtype and mutant ZFP36L1 as well as whole transcriptome sequencing of bladder cancer cells ± tet-on ZFP36L1, was performed. A network of 1,410 genes was identified as potential direct targets of ZFP36L1, including HIF1A, CCND1, and E2F1. ZFP36L1 specifically bound to the 3' UTRs of these targets for RNA degradation, thus suppressing their expression. Collectively, our findings reveal an indispensable role of ZFP36L1 as a post-transcriptional safeguard against aberrant hypoxic signaling and abnormal cell cycle progression.

2020-10-02 | GSE136181 | GEO

Rapamycin treatment of CEM_C1 cells 24 hours

Project description:Drug resistance remains a major obstacle to successful cancer treatment. Here we use a novel approach to identify rapamycin as a glucocorticoid resistance reversal agent. A database of drug-associated gene expression profiles was screened for molecules whose profile overlapped with a gene expression signature of glucocorticoid (GC) sensitivity/resistance in Acute Lymphoblastic Leukemia (ALL) cells. The screen indicated the mTOR inhibitor rapamycin profile matched the signature of GC-sensitivity. We thus tested the hypothesis that rapamycin would induce GC sensitivity in lymphoid malignancy cells, and found that it sensitized cells to glucocorticoid induced apoptosis via modulation of antiapoptotic MCL1. These data indicate that MCL1 is an important regulator of GC-induced apoptosis, and that the combination of rapamycin and glucocorticoids has potential utility in ALL. Furthermore this approach represents a novel strategy for identification of promising combination therapies for cancer. Keywords: drug treatment

2006-09-14 | GSE5821 | GEO

NSCLC cells treated with Gefitinib

Project description:About 10% of all NSCLC patients respond to gefitnib treatment and all of these patients will acquire resistance to the EGFR TKI. We used microarray to look at global gene expression changes in untreated cells vs gefitinib treated cells to identify key characters for the acquisition of resistance. NSCLC cells, H322c, were cultured 4 days in media containing 1?M gefitinib or 0.1% DMSO as a control. On day 4, RNA was extracted and submitted for microarray hybridization.

2011-01-27 | E-GEOD-23206 | biostudies-arrayexpress

Transcriptomic profiling of 5 dpf zebrafish livers following 24 hours of exposure to arsenic

Project description:This study was carried out to compare potential changes in the gene expression in 5 dpf livers between untreated, 1.0 and 1.5mM iAs exposures.

2021-08-31 | GSE156415 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data